Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-22-002075
Filing Date
2022-01-19
Accepted
2022-01-19 21:45:16
Documents
2
Period of Report
2022-01-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 1417
2 EXHIBIT 24.1 brhc10032917_ex24-1.htm EX-24.1 10908
  Complete submission text file 0001140361-22-002075.txt   13982
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Issuer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 666 PLAINSBORO ROAD PLAINSBORO NJ 08536
Business Address
ENRIGHT ERIN S. (Reporting) CIK: 0001579347 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-11460 | Film No.: 22540514